DRF-7295

N/A

Report date: 2023/02/11 20:38:16
NME

Base Information

Drug NameDRF-7295
Drug Alias NameDRF-7295
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColorectal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFresenius Kabi Ag
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A